recombinant human thrombopoietin

Ukraine

Drugs containing this active substance

  • EMAPLAG®

    The drug is used to treat thrombocytopenia (low platelet count) caused by chemotherapy in patients with solid tumors, as well as to treat immune thrombocytopenia (ITP) if corticosteroids are ineffective. It is intended for patients at risk of bleeding.

    Form: solution for injection

    Active substance Dosage
    recombinant human thrombopoietin 15000 IU/ml

    ATC: B02BX

    Manufacturer: Shenyang Sunshine Pharmaceutical Co., Ltd.